Publications by authors named "Daniela Arzeni"

Claim this Profile
A
Antimicrobial Activity of Different Antimicrobial Peptides (AMPs) Against Clinical Methicillin-resistant Staphylococcus aureus (MRSA).
Eleonora Ciandrini, Gianluca Morroni, Daniela Arzeni, Wojciech Kamysz, Damian Neubauer

Curr Top Med Chem· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activity of the protegrin IB-367 alone and in combination compared with conventional antifungal agents against dermatophytes.
Oriana Simonetti, Carmela Silvestri, Daniela Arzeni, Oscar Cirioni, Wojciech Kamysz

Mycoses· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An atypical, pigment-producing Metschnikowia strain from a leukaemia patient.
Vincenzo Savini, Marijke Hendrickx, Maurizio Sisti, Gioviana Masciarelli, Marco Favaro, Daniela Arzeni

Med Mycol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intestinal parasitosis: data analysis 2006-2011 in a teaching hospital of Ancona, Italy.
Carmela Silvestri, Gianfranco Greganti, Daniela Arzeni, Angela Morciano, Pamela Castelli

Infez Med· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents.
Francesco Barchiesi, Carmela Silvestri, Daniela Arzeni, Giulia Ganzetti, Sefora Castelletti

Med Mycol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activity of the synthetic lipopeptide PAL-Lys-Lys-NH(2) alone and in combination with antifungal agents against clinical isolates of Cryptococcus neoformans.
Francesco Barchiesi, Andrea Giacometti, Oscar Cirioni, Daniela Arzeni, Carmela Silvestri

Peptides· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of caspofungin against Candida guilliermondii and Candida parapsilosis.
Francesco Barchiesi, Elisabetta Spreghini, Serena Tomassetti, Agnese Della Vittoria, Daniela Arzeni

Antimicrob Agents Chemother· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the fungicidal activities of caspofungin and amphotericin B against Candida glabrata.
Francesco Barchiesi, Elisabetta Spreghini, Serena Tomassetti, Daniela Arzeni, Daniele Giannini

Antimicrob Agents Chemother· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caspofungin in combination with amphotericin B against Candida glabrata.
Francesco Barchiesi, Elisabetta Spreghini, Annette W Fothergill, Daniela Arzeni, Gianfranco Greganti

Antimicrob Agents Chemother· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential therapy with caspofungin and fluconazole for Candida albicans infection.
Francesco Barchiesi, Elisabetta Spreghini, Isabella Baldassarri, Anna Marigliano, Daniela Arzeni

Antimicrob Agents Chemother· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antifungal susceptibility patterns of yeast isolates causing bloodstream infections.
Francesco Barchiesi, Giuseppina Caggiano, Monia Maracci, Daniela Arzeni, Giorgio Scalise

J Antimicrob Chemother· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo anticryptococcal activities of a new pyrazolo-isothiazole derivative.
Francesco Barchiesi, Maria E Milici, Daniela Arzeni, Anna M Schimizzi, Giuseppe Pizzo

J Antimicrob Chemother· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Point prevalence, microbiology and fluconazole susceptibility patterns of yeast isolates colonizing the oral cavities of HIV-infected patients in the era of highly active antiretroviral therapy.
Francesco Barchiesi, Monia Maracci, Brunella Radi, Daniela Arzeni, Isabella Baldassarri

J Antimicrob Chemother· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis